Ingevity Corporation (NYSE:NGVT) Given Average Recommendation of “Hold” by Brokerages

Shares of Ingevity Corporation (NYSE:NGVT) have been given a consensus rating of “Hold” by the five research firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $80.00.

NGVT has been the subject of several recent analyst reports. Weiss Ratings raised shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Wall Street Zen cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st.

Insider Buying and Selling at Ingevity

In related news, SVP Ryan C. Fisher sold 2,709 shares of Ingevity stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total transaction of $199,707.48. Following the completion of the sale, the senior vice president owned 15,722 shares of the company’s stock, valued at approximately $1,159,025.84. This trade represents a 14.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David H. Li sold 5,000 shares of Ingevity stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the sale, the chief executive officer directly owned 120,636 shares of the company’s stock, valued at $9,147,827.88. This represents a 3.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 17,801 shares of company stock worth $1,347,481. Insiders own 0.88% of the company’s stock.

Institutional Trading of Ingevity

Several institutional investors and hedge funds have recently modified their holdings of the business. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Ingevity during the 2nd quarter valued at about $254,000. California State Teachers Retirement System increased its position in shares of Ingevity by 7,309.2% in the second quarter. California State Teachers Retirement System now owns 3,003,451 shares of the company’s stock worth $224,268,000 after purchasing an additional 2,962,914 shares during the last quarter. Nykredit A S bought a new position in shares of Ingevity in the second quarter worth approximately $158,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Ingevity by 3.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 163,469 shares of the company’s stock valued at $12,206,000 after purchasing an additional 5,848 shares in the last quarter. Finally, Hsbc Holdings PLC purchased a new stake in Ingevity in the second quarter valued at approximately $1,568,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Ingevity Stock Performance

Shares of NGVT opened at $69.57 on Thursday. Ingevity has a 52-week low of $45.85 and a 52-week high of $79.29. The stock’s 50-day simple moving average is $73.68 and its 200 day simple moving average is $71.83. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. The stock has a market capitalization of $2.39 billion, a price-to-earnings ratio of 47.33 and a beta of 1.16.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The business had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts forecast that Ingevity will post 5.4 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.